Advertisement
CLOV vs HUM
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLOV is a Buy and HUM is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CLOV’s FA Score shows that 1 FA rating(s) are green whileHUM’s FA Score has 3 green FA rating(s).
- CLOV’s FA Score: 1 green, 4 red.
- HUM’s FA Score: 3 green, 2 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CLOV’s TA Score shows that 4 TA indicator(s) are bullish while HUM’s TA Score has 3 bullish TA indicator(s).
- CLOV’s TA Score: 4 bullish, 4 bearish.
- HUM’s TA Score: 3 bullish, 5 bearish.
Price Growth
CLOV (@Managed Health Care) experienced а +6.47% price change this week, while HUM (@Managed Health Care) price change was -2.80% for the same time period.
The average weekly price growth across all stocks in the @Managed Health Care industry was +0.72%. For the same industry, the average monthly price growth was +14.43%, and the average quarterly price growth was +37.57%.
Reported Earning Dates
CLOV is expected to report earnings on Aug 10, 2026.
HUM is expected to report earnings on Jul 29, 2026.
Industries' Descriptions
@Managed Health Care (+0.72% weekly)Managed healthcare industry focuses on providing health/medical and disability insurance plans, generally intended to reduce the cost of for-profit health care. The insurance products might be provided through employer-paid (fully or partly) insurance and benefit programs, or through Medicare/Medicaid. Some of the largest providers of managed health care include Aetna, Humana Inc., and Cigna, and UnitedHealthcare.
| CLOV | HUM | CLOV / HUM | |
| Capitalization | 2.66B | 43.1B | 6% |
| EBITDA | -55.21M | N/A | - |
| Gain YTD | 117.915 | 40.926 | 288% |
| P/E Ratio | N/A | 38.50 | - |
| Revenue | 2.21B | 137B | 2% |
| Total Cash | 204M | 22B | 1% |
| Total Debt | 3.67M | 14B | 0% |
CLOV | HUM | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 41 | 20 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 29 Undervalued | 11 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 96 | 95 | |
PRICE GROWTH RATING 1..100 | 35 | 4 | |
P/E GROWTH RATING 1..100 | 100 | 8 | |
SEASONALITY SCORE 1..100 | 50 | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
HUM's Valuation (11) in the Managed Health Care industry is in the same range as CLOV (29) in the null industry. This means that HUM’s stock grew similarly to CLOV’s over the last 12 months.
HUM's Profit vs Risk Rating (100) in the Managed Health Care industry is in the same range as CLOV (100) in the null industry. This means that HUM’s stock grew similarly to CLOV’s over the last 12 months.
HUM's SMR Rating (95) in the Managed Health Care industry is in the same range as CLOV (96) in the null industry. This means that HUM’s stock grew similarly to CLOV’s over the last 12 months.
HUM's Price Growth Rating (4) in the Managed Health Care industry is in the same range as CLOV (35) in the null industry. This means that HUM’s stock grew similarly to CLOV’s over the last 12 months.
HUM's P/E Growth Rating (8) in the Managed Health Care industry is significantly better than the same rating for CLOV (100) in the null industry. This means that HUM’s stock grew significantly faster than CLOV’s over the last 12 months.
| CLOV | HUM | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 88% | 2 days ago 71% |
| Stochastic ODDS (%) | 2 days ago 86% | 2 days ago 69% |
| Momentum ODDS (%) | N/A | N/A |
| MACD ODDS (%) | 2 days ago 72% | 2 days ago 59% |
| TrendWeek ODDS (%) | 2 days ago 82% | 2 days ago 66% |
| TrendMonth ODDS (%) | 2 days ago 82% | 2 days ago 60% |
| Advances ODDS (%) | 2 days ago 81% | 9 days ago 60% |
| Declines ODDS (%) | 21 days ago 87% | 6 days ago 67% |
| BollingerBands ODDS (%) | 2 days ago 77% | 2 days ago 68% |
| Aroon ODDS (%) | 2 days ago 85% | 2 days ago 56% |
Advertisement
CLOV and
Correlation & Price change
A.I.dvisor tells us that CLOV and OSCR have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CLOV and OSCR's prices will move in lockstep.
| Ticker / NAME | Correlation To CLOV | 1D Price Change % | ||
|---|---|---|---|---|
| CLOV | 100% | +2.42% | ||
| OSCR - CLOV | 32% Poorly correlated | +0.49% | ||
| UNH - CLOV | 31% Poorly correlated | +1.43% | ||
| HUM - CLOV | 30% Poorly correlated | +0.02% | ||
| ALHC - CLOV | 29% Poorly correlated | -2.65% | ||
| PGNY - CLOV | 23% Poorly correlated | +0.77% | ||
More | ||||